Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Chiba; Shigeru
Address:
Kawasaki, JP
No. of patents:
13
Patents:












Patent Number Title Of Patent Date Issued
7238501 Process for producing trans-4-hydroxy-L-proline July 3, 2007
The present invention is directed to a process for producing trans-4-hydroxy-L-proline, which is useful as a raw material for medicines or as an additive to foods. In the process, L-proline is converted into trans-4-hydroxy-L-proline in the presence of an enzyme source which is deriv
7112432 Process for producing cis-3-hydroxy-L-proline September 26, 2006
An isolated gene encodes for a L-proline-3-hydroxylase having the amino acid sequence of SEQ ID NOS: 1, 2, 15, 16 and 17, or for a protein having enzymatic activity to hydroxylate the 3-position of L-proline and to act on free L-proline in the presence of 2-ketoglutaric acid and divalent
6767726 Process for producing cis-3-hydroxy-L-proline July 27, 2004
An isolated gene encodes for a L-proline-3-hydroxylase having the amino acid sequence of SEQ ID NOS: 1, 2, 15, 16 and 17, or for a protein having enzymatic activity to hydroxylate the 3-position of L-proline and to act on free L-proline in the presence of 2-ketoglutaric acid and divalent
6642355 Endothelin-antagonizing peptide November 4, 2003
The invention relates to an endothelin antagonistic peptide of the formula (I):wherein represents Asn or Asp; B represents His or Lys; E represents Ala or Ser; G represents Ala or Pro; X represents X.sup.1 -Gly or ##STR1## and Y represents hydroxy, lower alkoxy, amino, #
6617140 Process for producing trans-4-hydroxy-L-proline September 9, 2003
Provided is an industrially applicable process for producing trans-4-hydroxy-L-proline, which is useful as a raw material for medicines or as an additive to foods. In the process, L-proline is converted into trans-4-hydroxy-L-proline in the presence of an enzyme source which is deriv
6413748 Process for producing CIS-3-hydroxy-L-proline July 2, 2002
An industrially applicable process for producing cis-3-hydroxy-L-proline, which is useful as a raw material for medicines or as an additive to foods. In the process, L-proline is converted into cis-3-hydroxy-L-proline in the presence of an enzyme source which is derived from a microorgan
6242231 Process for producing trans-4-hydroxy-L-proline June 5, 2001
An industrially applicable process for producing trans-4-hydroxy-L-proline, which is useful as a raw material for medicines or as an additive to foods. In the process, L-proline is converted into trans-4-hydroxy-L-proline in the presence of an enzyme source which is derived from a mi
6194195 Strains of streptomyces producing endothelin antagonistic peptides February 27, 2001
The invention relates to biologically pure cultures of Streptomyces sp. RE-701 (FERM BP-3624) and Streptomyces sp. RE-629 (FERM BP-4126) that produce endothelin antagonistic peptides.
6010891 Process for producing Cis-3-hydroxy-L-proline January 4, 2000
An industrially applicable process for producing cis-3-hydroxy-L-proline, which is useful as a raw material for medicines or as an additive to foods. In the process, L-proline is converted into cis-3-hydroxy-L-proline in the presence of an enzyme source which is derived from a microorgan
5962292 Process for producing cis-3-hydroxy-L-proline October 5, 1999
An industrially applicable process for producing cis-3-hydroxy-L-proline, which is useful as a raw material for medicines or as an additive to foods. In the process, L-proline is converted into cis-3-hydroxy-L-proline in the presence of an enzyme source which is derived from a microorgan
5854040 Process for producing trans-4-hydroxy-L-proline December 29, 1998
Isolated and purified L-proline-4-hydroxylase which catalyzes hydroxylation of L-proline at the 4-position of L-proline in the presence of 2-ketoglutaric acid and a divalent iron ion to produce trans-4-hydroxy-L-proline. The L-proline-4-hydroxylase may be isolated from a microorganis
5656736 Compound UCH9 August 12, 1997
The present invention relates to the compound UCH9 represented by the following formula: ##STR1## which has antibacterial and anti-tumor activity, and pharmaceutically acceptable salts thereof.
5639860 Endothelin-antagonizing peptide June 17, 1997
Peptides represented by the following formula (I): ##STR1## wherein A represents Asn or Asp; B represents His or Lys; and E represents Ala or Ser;(1) X.sup.1 and Y.sup.1 are combined together to form a single bond as X.sup.1 --Y1, or (2) X.sup.1 represents hydrogen and Y.sup.1 repres










 
 
  Recently Added Patents
Anti-FGFR3 antibodies and methods using same
HYR1 as a target for active and passive immunization against Candida
Semiconductor IC including pulse generation logic circuit
Trading related to fund compositions
Method and system for enabling rendering of electronic media content via a secure ad hoc network configuration utilizing a handheld wireless communication device
Onium salt-containing polymer
Carrier for developing electrostatic charge image, developer for developing electrostatic charge image, image forming apparatus, and image forming method
  Randomly Featured Patents
Modular graft assembly
Vertical external cavity surface emitting laser (VECSEL)
Exposure system and exposure method
Engageable metal seal pressure balanced stab
Programmable fuse/non-volatile memory structures using externally heated phase change material
IC transporting apparatus, IC posture altering apparatus and IC take-out apparatus
Resin systems for high energy electron curable resin coated webs
Process and intermediates for preparing integrase inhibitors
Compact V-type internal combustion engine
Selectively thin silicon film for creating fully and partially depleted SOI on same wafer